Your browser doesn't support javascript.
loading
Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19.
Tran, Florian; Harris, Danielle M M; Scharmacher, Alena; Graßhoff, Hanna; Sterner, Kristina; Schinke, Susanne; Käding, Nadja; Humrich, Jens Y; Cabral-Marques, Otávio; Bernardes, Joana P; Mishra, Neha; Bahmer, Thomas; Franzenburg, Jeanette; Hoyer, Bimba F; Glück, Andreas; Guggeis, Martina; Ossysek, Alexander; Küller, Andre; Frank, Derk; Lange, Christoph; Rupp, Jan; Heyckendorf, Jan; Gaede, Karoline I; Amital, Howard; Rosenstiel, Philip; Shoenfeld, Yehuda; Halpert, Gilad; Rosenberg, Avi Z; Schulze-Forster, Kai; Heidecke, Harald; Riemekasten, Gabriela; Schreiber, Stefan.
Afiliação
  • Tran F; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Harris DMM; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Scharmacher A; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Graßhoff H; Institute for Human Nutrition and Food Science, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Sterner K; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Schinke S; Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Käding N; Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Humrich JY; Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Cabral-Marques O; Department of Infectious Diseases and Microbiology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Bernardes JP; Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Mishra N; Department of Immunology, Instituto de Ciencias Biomedicas, Universidade de São Paulo, São Paulo, SP, Brazil.
  • Bahmer T; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil.
  • Franzenburg J; Network of Immunity in Infection, Malignancy, and Autoimmunity, Universal Scientific Education and Research Network, Sao Paulo, SP, Brazil.
  • Hoyer BF; Department of Medicine, Division of Molecular Medicine, University of São Paulo School of Medicine, São Paulo, Brazil.
  • Glück A; Laboratory of Medical Investigation 29, University of São Paulo School of Medicine, São Paulo, Brazil.
  • Guggeis M; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Ossysek A; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Küller A; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Frank D; LungenClinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Lange C; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Rupp J; Institute of Clinical Chemistry, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Heyckendorf J; Section for Rheumatology, Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Gaede KI; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Amital H; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Rosenstiel P; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Shoenfeld Y; Institute of Clinical Molecular Biology, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Halpert G; Department of Internal Medicine III, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Rosenberg AZ; Department of Internal Medicine III, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Schulze-Forster K; German Centre for Cardiovascular Research (DZHK), partner site Hamburg, Kiel, Lübeck, Germany.
  • Heidecke H; Research Center Borstel, Borstel, Germany.
  • Riemekasten G; German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.
  • Schreiber S; Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany.
ERJ Open Res ; 8(4)2022 Oct.
Article em En | MEDLINE | ID: mdl-36575710

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: ERJ Open Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: ERJ Open Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha